The Nellcor Bedside SpO2 Patient Monitoring System provides clinicians with access to real-time patient respiratory status information including continuous SpO2, pulse rate monitoring and trending ...

Covidien has announced it has received FDA clearance to market the Covidien Nellcor Bedside SpO2 Patient Monitoring System, according to a news release. The Nellcor Bedside SpO2 system includes the ...

EarlySense, a patient care device maker, has received FDA clearance for its bedside system and central display with oximetry integration, according to AZ Sensors.

EarlySense, a patient care device maker, has received FDA clearance for its bedside system and central display with oximetry integration, according to AZ Sensors. The system is a continuous patient ...

Waltham-based EarlySense Inc. said today it has received U.S. Food and Drug Administration clearance for an updated version of its bedside system that monitors and documents vital signs in patients.

Covidien Achieves CE Mark for the Nellcor™ Bedside SpO2 Patient Monitoring System, PM100N. 20.11.2014 - Update : 20.11.2014 ...

CalmWave Advances Pilot After Demonstrating Potential to Improve Safety in Bedside Monitoring. ... About Wellstar Health System. At Wellstar, people are at the center of everything we do.

The OptiScanner 6000, is the Hayward, California-based company’s follow-up to its OptiScanner 5000, a bedside glucose monitoring system for critically ill patients.

Puducherry, Mar 13 (PTI): The remote on line bedside monitoring system being followed in centrally administered JIPMER will soon be adopted in hospitals nationwide.

The Food and Drug Adminstration on Wednesday granted market clearance to OptiScan Biomedical Corp.'s OptiScanner 5000 Glucose Monitoring System for use in the surgical intensive care unit.

OptiScan Biomedical, which focuses on patient monitoring in the intensive care unit, scored an FDA nod for its bedside device that continuously monitors patients’ glucose levels. The OptiScanner ...